Skip to main content
SpringerLink
Log in

RHD Genotyping from Maternal Plasma: Guidelines and Technical Challenges

  • Protocol
Prenatal Diagnosis

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 444))

Summary

Rhesus D (RhD) blood group incompatibility between mother and fetus can occasionally result in maternal alloimmunization where the resultant anti-D can cross the placenta and attack the fetal red cells, which in worse case scenarios can cause fetal anemia and ultimately death. Fetal RHD genotyping was introduced in the mid-1990s after the molecular characterization of the RH genes as an aid to the clinical management of these cases. Initially, these tests used fetal DNA extracted invasively from chorionic villus and amniocyte samples.

RHD genotyping of fetuses carried by RhD-negative women has become the first large-scale application of noninvasive prenatal diagnosis (NIPD). Initially the real-time polymerase chain reaction (PCR)-based tests were devised to characterize free fetal DNA in maternal plasma and serum, and RHD genotyping was a convenient assay to develop this exciting new technology, because the accuracy of tests could easily be confirmed after the simple RhD phenotyping of fetal cord blood cells after birth. “First generation” RHD genotyping tests were based on the incorrect concept that all D-negative phenotypes were caused by a complete RHD gene deletion. Thus, it was a relatively simple task to develop diagnostic PCR strategies based on the detection of RHD where D-negative genomes will completely lack RHD. Subsequent research into the molecular basis of D-negative phenotypes revealed that a significant number of D-negative genomes possess fragments of, or mutated RHD genes, the most notable of which is the RHD pseudogene found in Africans. Thus, more comprehensive RHD genotyping tests have evolved to differentiate these alleles, and are more appropriate in the diagnosis of multi-ethnic population groups such as those found in Europe and North America.

Many European Union countries have suggested the mass application of RHD NIPD for all fetuses carried by D-negative women. This is of clear benefit, because most RhD prophylaxis programs have switched to antenatal administration. This will help conserve anti-D stocks and it will prevent unnecessary administration of a human-derived blood product to a vulnerable patient group. Although anti-D stocks are inherently safe, there is a moral obligation to eliminate unnecessary administration of it because there have been instances of hepatitis C infection due to contamination. Furthermore, as yet undescribed viruses may be contaminants of blood products. Mass-scale RHD NIPD will shortly be implemented in several countries in the European Community as a consequence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Reference

  1. Urbaniak, S. J. and Greiss, M. A. (2000) RhD haemolytic disease of the fetus and the newborn. Blood Rev. 14, 44–61.

    Article  CAS  PubMed  Google Scholar 

  2. Hadley, A. G., Poole, G. D., Poole, J., Anderson, N. A., and Robson, M. (1996) Haemolytic disease of the newborn due to anti-G. Vox Sang. 71, 108–112.

    Article  CAS  PubMed  Google Scholar 

  3. Avent, N. D., Madgett, T. E., Lee, Z. E., Head, D. J., Maddocks, D. G., and Skinner, L. H. (2006) Molecular biology of Rh proteins and relevance to molecular medicine. Expert Rev. Mol. Med. 8, 1–20.

    Article  PubMed  Google Scholar 

  4. Avent, N. D. and Reid, M. E. (2000) The Rh blood group system: a review. Blood 95, 375–387.

    CAS  PubMed  Google Scholar 

  5. Van Kim, C. L., Colin, Y., and Cartron, J. P. (2005) Rh proteins: key structural and functional components of the red cell membrane. Blood Rev. 20, 93–110.

    PubMed  Google Scholar 

  6. Huang, C. H. and Liu, P. Z. (2001) New insights into the Rh superfamily of genes and proteins in erythroid cells and nonerythroid tissues. Blood Cells Mol. Dis. 27, 90–101.

    Article  CAS  PubMed  Google Scholar 

  7. Wagner, F. F. and Flegel, W. A. (2004) Review: the molecular basis of the Rh blood group phenotypes. Immunohematology 20, 23–36.

    CAS  PubMed  Google Scholar 

  8. Westhoff, C. M. (2004) The Rh blood group system in review: a new face for the next decade. Transfusion 44, 1663–1673.

    Article  CAS  PubMed  Google Scholar 

  9. Conroy, M. J., Bullough, P. A., Merrick, M., and Avent, N. D. (2005) Modelling the human rhesus proteins: implications for structure and function. Br. J. Haematol. 131, 543–551.

    Article  CAS  PubMed  Google Scholar 

  10. Stott, L. M., Barker, R. N., and Urbaniak, S. J. (2000) Identification of alloreactive T-cell epitopes on the Rhesus D protein. Blood 96, 4011–4019.

    CAS  PubMed  Google Scholar 

  11. Hall, A. M., Cairns, L. S., Altmann, D. M., Barker, R. N., and Urbaniak, S. J. (2005) Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 105, 2175–2179.

    Article  CAS  PubMed  Google Scholar 

  12. Cherif-Zahar, B., Bloy, C., Van Kim, C. L., et al. (1990) Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc. Natl. Acad. Sci. USA 87, 6243–6247.

    Article  CAS  PubMed  Google Scholar 

  13. Avent, N. D., Finning, K. M., Martin, P. G., and Soothill, P. W. (1990) cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression. Biochem. J. 271, 821–825.

    CAS  PubMed  Google Scholar 

  14. Arce, M. A., Thompson, E. S., Wagner, S., Coyne, K. E., Ferdmann, B. A., and Lublin, D. M. (1993) Molecular cloning of RhD cDNA derived derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood 82,651–655.

    CAS  PubMed  Google Scholar 

  15. Van Kim, C. L., Mouro. I., Cherif-Zahar, B., et al. (1992) Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc. Natl. Acad. Sci. USA 89, 10925–10929.

    Article  Google Scholar 

  16. Avent, N. D. (2002) Fetal genotyping. In: Hadley, A. G. and Soothill, P. W. (eds.). Alloimmune disorders of pregnancy, pp 121–139. Cambridge University Press, Cambridge, UK.

    Google Scholar 

  17. Avent, N. D., Finning, K. M., Martin, P. G., and Soothill, P. W. (2000) Prenatal determination of fetal blood group status. Vox Sang. 78, 155–162.

    CAS  PubMed  Google Scholar 

  18. Avent, N. D. (1998) Antenatal genotyping of the blood groups of the fetus. Vox Sang. 74, 365–374.

    CAS  PubMed  Google Scholar 

  19. Bloy, C., Blanchard, D., Dahr, W., Beyreuther, K., Salmon, C., and Cartron, J. P. (1988) Determination of the N-terminal sequence of human red cell Rh(D) polypeptide and demonstration that the Rh(D), (c), and (E) antigens are carried by distinct polypeptide chains. Blood 72, 661–666.

    CAS  PubMed  Google Scholar 

  20. Avent, N. D., Ridgwell, K., Wanner, M. J., and Anstee, D. J. (1988) Protein-sequence studies on Rh-related polypeptides suggest the presence of at least two groups of proteins which associate in the human red-cell membrane. Biochem. J. 256, 1043–1046.

    CAS  PubMed  Google Scholar 

  21. Saboori, A. M., Smith, B. L., and Agre, P. (1988) Polymorphism in the Mr 32,000 Rh protein purified from Rh(D)-positive and -negative erythrocytes. Proc. Natl. Acad. Sci. USA 85, 4042–4045.

    Article  CAS  PubMed  Google Scholar 

  22. Bennett, P. R., Le Van Kim, C., Colin, Y., Warwick, R. M., Cherif-Zahar, R., Fisk, N. and Cartron, J. P. (1993) Prenatal determination of fetal RhD type by DNA amplification. N. Engl. J. Med. 329, 607–610.

    Article  CAS  PubMed  Google Scholar 

  23. Colin, Y., Cherif-Zahar, F., Le Van Kim, C., Raynal, V., Van Huffel, V., and Cartron, J. P. (1991) Genetic basis of the RhD-positive and RhD-positive and RhD-negative blood group polymorphism as analysis. Blood 78, 2747–2752.

    CAS  PubMed  Google Scholar 

  24. Ridgwell, K., Spurr, N. K., Laguda, B., MacGeoch, C., Avent, N. D. and Tanner, M. J. (1992) Isolation of cDNA clones for a 50 kDa glycoprotein of the human erythrocyte membrane associated with Rh (rhesus) blood-group antigen expression. Biochem. J. 287, 223–338.

    CAS  PubMed  Google Scholar 

  25. Wagner, F. F. and Flegel, W. A. (2000) RHD gene deletion occurred in the Rhesus box. Blood 95, 3662–3668.

    CAS  PubMed  Google Scholar 

  26. Wagner, F. F., Moulds, J. M., and Flegel, W. A. (2005) Genetic mechanisms of Rhesus box variation. Transfusion 45, 338–344.

    Article  PubMed  Google Scholar 

  27. Matheson, K. A. and Denomme, G. A. (2002) Novel 3′ Rhesus box sequences confound RHD zygosity assignment. Transfusion 42, 645–650.

    Article  CAS  PubMed  Google Scholar 

  28. Engelfriet, C. P., Reesink, H. W., Judd, W. J., et al. (2003) Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang. 85, 328–337.

    Article  CAS  PubMed  Google Scholar 

  29. Urbaniak, S. J. (1998) Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists. Transfusion. 38, 97–99.

    Article  CAS  PubMed  Google Scholar 

  30. Van der Schoot, C. E., Soussan, A. A., Koelewijn, J., Bonsel, G., Paget-Christiaens, L. G., and de Haas, M. (2006) Non-invasive antenatal RHD typing. Transfus. Clin. Biol. 13, 53–57.

    Article  PubMed  Google Scholar 

  31. Finning, K., Martin, P. and Daniels, G. (2004) A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann. N Y Acad. Sci. 1022, 119–123.

    Article  CAS  PubMed  Google Scholar 

  32. Rouillac-Le Sciellour, C., Puillandre, P., Gillot, R., et al. (2004) Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol. Diagn. 8, 23–31.

    Article  Google Scholar 

  33. Gautier, E., Benachi, A., Giovangrand, Y., et al., (2005) Fetal RhD genotyping by maternal serum analysis: a two-year experience. Am. J. Obstet. Gynecol. 192, 666–669.

    Article  CAS  PubMed  Google Scholar 

  34. Lubenko, A., Contreras, M., and Habash, J. (1989) Should anti-Rh immunoglobulin be given D variant women? Br. J. Hematol. 72, 429–433.

    Article  CAS  Google Scholar 

  35. Lacey, P. A., Caskey, C. R., Werner, D. J., and Moulds, J. J. (1983) Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 23, 91–94.

    Article  CAS  PubMed  Google Scholar 

  36. Flegel, W. A. (2006) Molecular genetics of RH and its clinical application Genetique moleculaire sur systeme RH et ses applications cliniques. Transfus. Clin. Biol. 13, 4–12.

    Article  CAS  PubMed  Google Scholar 

  37. Avent, N. D. (2001) Molecular biology of the Rh blood group system. J. Pediatr. Hematol. Oncol. 23, 394–402.

    Article  CAS  PubMed  Google Scholar 

  38. Avent, N. D. (1999) The rhesus blood group system: insights from recent advances in molecular biology. Transfus. Med. Rev. 13, 245–266.

    Article  CAS  PubMed  Google Scholar 

  39. Denomme, G. A. (2004) The structure and function of the molecules that carry human red blood cell and platelet antigens. Transfus. Med. Rev. 18,203–231.

    Article  PubMed  Google Scholar 

  40. Simsek, S., Bleeker, P. M. and von dem Borne, A. E. (1994) Prenatal determination of fetal RhD type. N. Engl. J. Med. 330, 795–796.

    Article  CAS  PubMed  Google Scholar 

  41. Carritt, B., Steers, F. J., and Avent, N. D. (1994) Prenatal determination of fetal RhD type. Lancet 344, 205–206.

    Article  CAS  PubMed  Google Scholar 

  42. Avent, N. D., Martin, P. G., Armstrong-Fisher, S. S., et al. (1997) Evidence of genetic diversity underlying Rh D-, weak D (Du), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood 89, 2568–2577.

    CAS  PubMed  Google Scholar 

  43. Andrews, K. T., Wolter, L. C., Saul, A., and Hyland, C. A. (1998) The RhD– trait in a white patient with the RhCCee phenotype attributed to a four-nucleotide deletion in the RHD gene. Blood 92, 1839–1840.

    CAS  PubMed  Google Scholar 

  44. Huang, C. H. (1996) Alteration of RH gene structure and expression in human dCCee and DCW-red blood cells: phenotypic homozygosity versus genotypic heterozygosity. Blood 88, 2326–2333.

    CAS  PubMed  Google Scholar 

  45. Wagner, F. F., Frohmajer, A., and Flegel, W. A. (2001) RHD positive haplotypes in D negative Europeans. BMC Genet. 2, 10.

    Article  CAS  PubMed  Google Scholar 

  46. Singleton, B. K., Green, C. A., Avent, N. D., et al. (2000) The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 95,12–18.

    Google Scholar 

  47. Daniels, G. L., Faas, B. H., Green, C. A., et al. (1998) The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion. 38, 951–958.

    Article  CAS  PubMed  Google Scholar 

  48. Faas, B. H., et al. (1997) Molecular background of VS and weak C expression in blacks. Transfusion 37, 38–44.

    Article  CAS  PubMed  Google Scholar 

  49. Finning, K. M., Martin, P. G., Soothill, P. W., and Avent, N. D. (2002) Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42, 1079–1085.

    Article  CAS  PubMed  Google Scholar 

  50. Jones, J. W., Lloyd-Evans, P., and Kumpel, B. M. (1996) Quantitation of Rh D antigen sites on weak D and D variant red cells by flow cytometry. Vox Sang. 71, 176–183.

    Article  CAS  PubMed  Google Scholar 

  51. Wagner, F. F., Gassner, C., Muller, T. H., Schonitzer, D., Schunter, F., and Flegel, W. A. (1998) Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features. Blood 91, 2157–2168.

    CAS  PubMed  Google Scholar 

  52. Mayne, K., Bowell, P., Woodward, T., Sibley, C., Lomas, C., and Tippett, P. (1990) Rh immunization by the partial D antigen of category DVa. Br. J. Haematol. 76, 537–539.

    Article  CAS  PubMed  Google Scholar 

  53. Leschek, E., Pearlman, S. A., Boudreaux, I., and Meek, R. (1993) Severe hemolytic disease of the newborn caused by anti-Gonzales antibody. Am. J. Perinatol. 10, 362–364.

    Article  CAS  PubMed  Google Scholar 

  54. Levene, C., Sela, R., Grunberg, L., Gale, R., Lomas, C., and Tippett, P. (1983) The Rh antigen Tar (Rh40) causing haemolytic disease of the newborn. Clin. Lab. Haematol. 5, 303–305.

    CAS  PubMed  Google Scholar 

  55. Gabra, G. S., Bruce, M., Watt, A., and Mitchell, R. (1987) Anti-Rh 29 in a primigravida with rhesus null syndrome resulting in haemolytic disease of the newborn. Vox Sang. 53, 143–146.

    Article  CAS  PubMed  Google Scholar 

  56. Lenkiewicz, B. and Zupanska, B. (2000) Moderate hemolytic disease of the newborn due to anti-Hr0 in a mother with the D–/D– phenotype. Immunohematology 16, 109–111.

    CAS  PubMed  Google Scholar 

  57. Lubenko, A., Contreras, M., Portugal, C. L., et al. (1992) Severe haemolytic disease in an infant born to an Rh(null) proposita. Vox Sang. 63, 43–47.

    Article  CAS  PubMed  Google Scholar 

  58. Zimmermann, B., El-Sheikhah, A., Nicolaides, K., Holzgreve, W., and Hahn, S. (2005) Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin. Chem. 51, 1598–1604.

    Article  CAS  PubMed  Google Scholar 

  59. Daniels, G., van der Schoot, C. E., and Olsson, M. L. (2005) Report of the First International Workshop on molecular blood group genotyping. Vox Sang. 88,136–142.

    Google Scholar 

  60. Alizadeh, M., Bernard, M., Danic, B., et al. (2002) Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 99, 4618–4625.

    Article  CAS  PubMed  Google Scholar 

  61. Chim, S. S., Tong, Y. K., Chiu, R. W., et al. (2005) Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc. Natl. Acad. Sci. USA 102, 14753–14758.

    Article  CAS  PubMed  Google Scholar 

  62. Chang, et al., (2006) Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem. 52, 2211–2218.

    Google Scholar 

  63. Lo, Y. M., Corbetta, N., Chamberlain, P. F., et al. (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485–487.

    Article  CAS  PubMed  Google Scholar 

  64. Legler, et al. (2007) Workshop report on the extraction of foetal DNA from maternal plasma. Prenatal Diagnosis 27, 824–829.

    Google Scholar 

  65. Madgett, T. E. (2005) Rapid molecular genotyping for RHD using multiplex ligation-dependent probe amplification technology. Transfusion 45, 129A.

    Google Scholar 

  66. Chan, K. C., Zhang, J., Hui, A. B., et al. (2004) Size distributions of maternal and fetal DNA in maternal plasma. Clin. Chem. 50, 88–92.\vvsp{-2}

    Article  CAS  PubMed  Google Scholar 

  67. Li, Y., Di Naro, E., Vitucci, A., Zimmermann, B., Holzgreve, W., and Hahn, S. (2005) Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. J. Am. Med. Assoc. 293, 843–849.

    Article  CAS  Google Scholar 

  68. Gassner, C., Doescher, A., Drnovsek, T. D., et al. (2005) Presence of RHD in serologically D–, C/E+ individuals: a European multicenter study. Transfusion. 45, 527–538.

    Article  CAS  PubMed  Google Scholar 

  69. Shao, C. P. and Xiong, W. (2004) A new hybrid RHD-positive, D antigen-negative allele. Transfus. Med. 14, 185–186.

    Article  PubMed  Google Scholar 

  70. Blunt, T., Daniels, G., and Carritt, B. (1994) Serotype switching in a partially deleted RHD gene. Vox Sang. 67, 397–401.

    Article  CAS  PubMed  Google Scholar 

  71. Faas, B. H., Beckers, E. A., Simsek, S., et al. (1996) Involvement of Ser103 of the Rh polypeptides in G epitope formation. Transfusion 36, 506–11.

    Article  CAS  PubMed  Google Scholar 

  72. Gassner, C., Schmarda A., Kilga-Nogler, S., et al. (1997) RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 37, 1020–1026.

    Article  CAS  PubMed  Google Scholar 

  73. Shao, C. P., Maas, J. H., Su, Y. Q., Kohler, M., and Legler, T. J. (2002) Molecular background of Rh D-positive, D-negative, D(el), and weak D phenotypes in Chinese. Vox Sang. 83, 156–161.

    Article  CAS  PubMed  Google Scholar 

  74. Cherif-Zahar, B., Bony, V., Steffensen, R., et al. (1998) Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia. Br. J. Haematol. 102, 1263–1270.

    Article  CAS  PubMed  Google Scholar 

  75. Okuda, H., Kawano, M., Iwamoto, S., et al. (1997) The RHD gene is highly detectable in RhD-negative Japanese donors. J. Clin. Invest. 100, 373–379.

    Article  CAS  PubMed  Google Scholar 

  76. Qun, X., Grootkerk-Tax, M. G., Maaskant-van Wijk, P. A., and van der Schoot, C. E. (2005) Systemic analysis and zygosity determination of the RHD gene in a D-negative Chinese Han population reveals a novel D-negative RHD gene. Vox Sang. 88, 35–40.

    Article  CAS  PubMed  Google Scholar 

  77. Kim, J. Y., Kim, S. Y., Kim, C. A., Yon, G. S., and Park, S. S. (2005) Molecular characterization of D– Korean persons: development of a diagnostic strategy. Transfusion 45, 345–352.

    Article  CAS  PubMed  Google Scholar 

  78. Faas, B. H., Beuling, E. A., Christiaens, G. C., von dem Borne, A. E., and van der Schoot, C. E. (1998) Detection of fetal RHD-specific sequences in maternal plasma. Lancet 352, 1196.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Research in Biomedicine, University of the West of England, Bristol, UK

    Neil D. Avent

Authors
  1. Neil D. Avent
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Laboratory for Prenatal Medicine and Gynecological Oncology, Department of Biomedicine, University Womens’s Hospital, Basel, Switzerland

    Sinuhe Hahn

  2. Department of Obstetrics and Gynecology, Drexel University College of Medicine, Philadelphia, PA

    Laird G. Jackson

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Avent, N.D. (2008). RHD Genotyping from Maternal Plasma: Guidelines and Technical Challenges. In: Hahn, S., Jackson, L.G. (eds) Prenatal Diagnosis. Methods in Molecular Biology™, vol 444. Humana Press. https://doi.org/10.1007/978-1-59745-066-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-066-9_14

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-803-4

  • Online ISBN: 978-1-59745-066-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation